Munster, Germany

Bernhard Kerner


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernhard Kerner: Innovator in Gamma Globulin Preparation

Introduction

Bernhard Kerner is a notable inventor based in Munster, Germany. He has made significant contributions to the field of medical science, particularly in the preparation of gamma globulin for intravenous administration. His innovative approach has the potential to enhance the efficacy and safety of gamma globulin treatments.

Latest Patents

Bernhard Kerner holds a patent for a process titled "Process for preparing gamma globulin suitable for intravenous." This improved method involves dissolving gamma globulin precipitated from blood or blood products in a solution. The process includes separating non-dissolved precipitate from the solution, adding polyethylene glycol, and further refining the gamma globulin for intravenous use. The patent outlines specific concentrations and steps to ensure the quality and effectiveness of the gamma globulin preparation.

Career Highlights

Kerner is associated with Armour Pharma GmbH, where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced methods for preparing medical products that can significantly impact patient care. With a patent count of 1 patent, he continues to contribute to the field with his research and development efforts.

Collaborations

Throughout his career, Bernhard Kerner has collaborated with esteemed colleagues, including Jurgen-Dietrich Friedrich-Fiechtl and Jurgen Holzapfel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Bernhard Kerner's contributions to the preparation of gamma globulin highlight his role as an innovator in the medical field. His patented process not only improves the quality of gamma globulin but also enhances its safety for intravenous administration. His work at Armour Pharma GmbH and collaborations with other professionals further underscore his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…